Literature DB >> 27129280

RNA-binding Protein Musashi Homologue 1 Regulates Kidney Fibrosis by Translational Inhibition of p21 and Numb mRNA.

Shreyas Jadhav1, Amrendra K Ajay1, Priyanka Trivedi1, Jenifer Seematti1, Kathryn Pellegrini1, Florin Craciun1, Vishal S Vaidya2.   

Abstract

RNA-binding proteins (RBPs) are recognized as key posttranscriptional regulators that not only modulate the spatiotemporal expression of genes during organism development but also regulate disease pathogenesis. Very limited information exists on the potential role of RBPs in modulating kidney fibrosis, which is a major hallmark of chronic kidney disease. Here, we report a novel mechanism in kidney fibrosis involving a RBP, Musashi homologue 1 (Msi1), which is expressed in tubular epithelial cells. Using two mechanistically distinct mouse models of kidney fibrosis, we show that Msi1 protein levels are significantly down-regulated in the kidneys following fibrosis. We found that Msi1 functions by negatively regulating the translation of its target mRNAs, p21 and Numb, whose protein levels are markedly increased in kidney fibrosis. Also, Msi1 overexpression and knockdown in kidney epithelial cells cause p21- and Numb-mediated cell cycle arrest. Furthermore, we observed that Numb looses its characteristic membrane localization in fibrotic kidneys and therefore is likely unable to inhibit Notch resulting in tubular cell death. Oleic acid is a known inhibitor of Msi1 and injecting oleic acid followed by unilateral ureteral obstruction surgery in mice resulted in enhanced fibrosis compared with the control group, indicating that inhibiting Msi1 activity renders the mice more susceptible to fibrosis. Given that deregulated fatty acid metabolism plays a key role in kidney fibrosis, these results demonstrate a novel connection between fatty acid and Msi1, an RNA-binding protein, in kidney fibrosis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  RNA binding protein; apoptosis; cell cycle; fatty acid; fibrosis; kidney

Mesh:

Substances:

Year:  2016        PMID: 27129280      PMCID: PMC4933168          DOI: 10.1074/jbc.M115.713289

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Mutations in the pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31 in Spanish families with autosomal dominant retinitis pigmentosa.

Authors:  María Martínez-Gimeno; María José Gamundi; Imma Hernan; Miquel Maseras; Elena Millá; Carmen Ayuso; Blanca García-Sandoval; Magdalena Beneyto; Concha Vilela; Montserrat Baiget; Guillermo Antiñolo; Miguel Carballo
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

Review 2.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

Review 3.  Fibrosis--a common pathway to organ injury and failure.

Authors:  Don C Rockey; P Darwin Bell; Joseph A Hill
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

4.  Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease.

Authors:  M Teresa Grande; Berta Sánchez-Laorden; Cristina López-Blau; Cristina A De Frutos; Agnès Boutet; Miguel Arévalo; R Grant Rowe; Stephen J Weiss; José M López-Novoa; M Angela Nieto
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440

5.  A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins.

Authors:  Gerard Minuesa; Christophe Antczak; David Shum; Constantin Radu; Bhavneet Bhinder; Yueming Li; Hakim Djaballah; Michael G Kharas
Journal:  Comb Chem High Throughput Screen       Date:  2014       Impact factor: 1.339

Review 6.  Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.

Authors:  N Riggi; L Cironi; M-L Suvà; I Stamenkovic
Journal:  J Pathol       Date:  2007-09       Impact factor: 7.996

7.  Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney.

Authors:  Hui-Teng Cheng; Jeffrey H Miner; MeeiHua Lin; Malú G Tansey; Kevin Roth; Raphael Kopan
Journal:  Development       Date:  2003-10       Impact factor: 6.868

8.  Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes.

Authors:  Raquel de Sousa Abreu; Patricia C Sanchez-Diaz; Christine Vogel; Suzanne C Burns; Daijin Ko; Tarea L Burton; Dat T Vo; Soudhamini Chennasamudaram; Shu-Yun Le; Bruce A Shapiro; Luiz O F Penalva
Journal:  J Biol Chem       Date:  2009-03-03       Impact factor: 5.157

9.  The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells.

Authors:  Parvaneh Nikpour; Modjtaba Emadi Baygi; Christine Steinhoff; Christiane Hader; Anna C Luca; Seyed J Mowla; Wolfgang A Schulz
Journal:  J Cell Mol Med       Date:  2010-05-14       Impact factor: 5.310

Review 10.  RNA-binding proteins and post-transcriptional gene regulation.

Authors:  Tina Glisovic; Jennifer L Bachorik; Jeongsik Yong; Gideon Dreyfuss
Journal:  FEBS Lett       Date:  2008-03-13       Impact factor: 4.124

View more
  19 in total

Review 1.  Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

Authors:  Alexander E Kudinov; John Karanicolas; Erica A Golemis; Yanis Boumber
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

2.  Targeting Phospholipase D4 Attenuates Kidney Fibrosis.

Authors:  Priyanka Trivedi; Ramya K Kumar; Ashwin Iyer; Sarah Boswell; Casimiro Gerarduzzi; Vivekkumar P Dadhania; Zach Herbert; Nikita Joshi; James P Luyendyk; Benjamin D Humphreys; Vishal S Vaidya
Journal:  J Am Soc Nephrol       Date:  2017-08-16       Impact factor: 10.121

Review 3.  RNA-binding proteins and their role in kidney disease.

Authors:  Michael Ignarski; Roman-Ulrich Müller; Lisa Seufert; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2021-11-03       Impact factor: 42.439

4.  Human oncoprotein Musashi-2 N-terminal RNA recognition motif backbone assignment and identification of RNA-binding pocket.

Authors:  Lan Lan; Minli Xing; Justin T Douglas; Philip Gao; Robert P Hanzlik; Liang Xu
Journal:  Oncotarget       Date:  2017-11-20

5.  Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.

Authors:  Hsiao-Yun Chen; Liang-Ting Lin; Mong-Lien Wang; Benoit Laurent; Chih-Hung Hsu; Chih-Ming Pan; Wan-Ru Jiang; Pau-Yuan Chen; Hsin-I Ma; Yi-Wei Chen; Pin-I Huang; Arthur Chiou; Shih-Hwa Chiou
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

6.  Ribosome profiling reveals a functional role for autophagy in mRNA translational control.

Authors:  Juliet Goldsmith; Timothy Marsh; Saurabh Asthana; Andrew M Leidal; Deepthisri Suresh; Adam Olshen; Jayanta Debnath
Journal:  Commun Biol       Date:  2020-07-17

7.  Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.

Authors:  Jang-Chun Lin; Jo-Ting Tsai; Tsu-Yi Chao; Hsin-I Ma; Wei-Hsiu Liu
Journal:  Neoplasia       Date:  2019-04-06       Impact factor: 5.715

8.  Tau oligomers mediate aggregation of RNA-binding proteins Musashi1 and Musashi2 inducing Lamin alteration.

Authors:  Mauro Montalbano; Salome McAllen; Urmi Sengupta; Nicha Puangmalai; Nemil Bhatt; Anna Ellsworth; Rakez Kayed
Journal:  Aging Cell       Date:  2019-09-18       Impact factor: 9.304

9.  Bagging Nearest-Neighbor Prediction independence Test: an efficient method for nonlinear dependence of two continuous variables.

Authors:  Yi Wang; Yi Li; Xiaoyu Liu; Weilin Pu; Xiaofeng Wang; Jiucun Wang; Momiao Xiong; Yin Yao Shugart; Li Jin
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

10.  Knockdown of MSI1 inhibits the proliferation of human oral squamous cell carcinoma by inactivating STAT3 signaling.

Authors:  Chen-Fei Wang; Hong-Chuang Zhang; Xin-Mei Feng; Xiao-Meng Song; Yu-Nong Wu
Journal:  Int J Mol Med       Date:  2019-05-06       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.